MetMaxStruct: A Tversky-Similarity-Based Strategy for Analysing the (Sub)Structural Similarities of Drugs and Endogenous Metabolites
暂无分享,去创建一个
[1] B. Fan,et al. Molecular similarity and diversity in chemoinformatics: From theory to applications , 2006, Molecular Diversity.
[2] David Flaxbart. Handbook of Chemoinformatics: From Data to Knowledge, Volumes 1−4 Edited by Johann Gasteiger (University of Erlangen-Nürnberg). Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim. 2003. xlvii + 1870 pp. $750.00. ISBN 3-527-30680-3. , 2004 .
[3] H. Hotelling. Analysis of a complex of statistical variables into principal components. , 1933 .
[4] Joshua D. Knowles,et al. An Evolutionary Approach to Multiobjective Clustering , 2007, IEEE Transactions on Evolutionary Computation.
[5] G. Superti-Furga,et al. A Call for Systematic Research on Solute Carriers , 2015, Cell.
[6] D. Kell,et al. Membrane transporter engineering in industrial biotechnology and whole cell biocatalysis. , 2015, Trends in biotechnology.
[7] Markus J. Herrgård,et al. A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology , 2008, Nature Biotechnology.
[8] Jürgen Bajorath,et al. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. , 2007, Drug discovery today.
[9] Frederico Gualberto F. Coelho,et al. Semi-supervised feature selection , 2013 .
[10] Pierre Baldi,et al. Bounds and Algorithms for Fast Exact Searches of Chemical Fingerprints in Linear and Sublinear Time , 2007, J. Chem. Inf. Model..
[11] Christian Senger,et al. StreptomeDB: a resource for natural compounds isolated from Streptomyces species , 2012, Nucleic Acids Res..
[12] Rajarshi Guha,et al. KNIME Workflow to Assess PAINS Filters in SMARTS Format. Comparison of RDKit and Indigo Cheminformatics Libraries , 2011, Molecular informatics.
[13] S. R. Harris,et al. STUDIES OF FLAVIN ADENINE DINUCLEOTIDE-REQUIRING ENZYMES AND PHENOTHIAZINES-I. INTERACTIONS OF CHLORPROMAZINE AND D-AMINO ACID OXIDASE. , 1965, Biochemical pharmacology.
[14] Sanjay K. Nigam,et al. What do drug transporters really do? , 2014, Nature Reviews Drug Discovery.
[15] Petra Schneider,et al. Distance phenomena in high‐dimensional chemical descriptor spaces: Consequences for similarity‐based approaches , 2009, J. Comput. Chem..
[16] W Patrick Walters,et al. Going further than Lipinski's rule in drug design , 2012, Expert opinion on drug discovery.
[17] R. Rivlin,et al. Inhibition of riboflavin metabolism in rat tissues by chlorpromazine, imipramine, and amitriptyline. , 1981, The Journal of clinical investigation.
[18] John Moody,et al. Fast Learning in Networks of Locally-Tuned Processing Units , 1989, Neural Computation.
[19] Yoshua Bengio,et al. Why Does Unsupervised Pre-training Help Deep Learning? , 2010, AISTATS.
[20] R. Glen,et al. Molecular similarity: a key technique in molecular informatics. , 2004, Organic & biomolecular chemistry.
[21] P. Sopp. Cluster analysis. , 1996, Veterinary immunology and immunopathology.
[22] Douglas B. Kell,et al. Understanding the foundations of the structural similarities between marketed drugs and endogenous human metabolites , 2015, Front. Pharmacol..
[23] Jürgen Bajorath,et al. Apparent Asymmetry in Fingerprint Similarity Searching is a Direct Consequence of Differences in Bit Densities and Molecular Size , 2007, ChemMedChem.
[24] Horst Bunke,et al. On a relation between graph edit distance and maximum common subgraph , 1997, Pattern Recognit. Lett..
[25] G. V. Paolini,et al. Global mapping of pharmacological space , 2006, Nature Biotechnology.
[26] Stefan Senger,et al. Using Tversky Similarity Searches for Core Hopping: Finding the Needles in the Haystack , 2009, J. Chem. Inf. Model..
[27] Veerabahu Shanmugasundaram,et al. Molecular similarity measures. , 2011, Methods in molecular biology.
[28] Xiaojin Zhu,et al. Semi-Supervised Learning , 2010, Encyclopedia of Machine Learning.
[29] Inaki Morao,et al. Drug discovery applications for KNIME: an open source data mining platform. , 2012, Current topics in medicinal chemistry.
[30] John J. Irwin,et al. ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..
[31] H. Koepsell. The SLC22 family with transporters of organic cations, anions and zwitterions. , 2013, Molecular aspects of medicine.
[32] Doris Chen,et al. The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity. , 2014, Nature chemical biology.
[33] Douglas B. Kell. How drugs pass through biological cell membranes – a paradigm shift in our understanding? , 2016 .
[34] D. Broomhead,et al. Radial Basis Functions, Multi-Variable Functional Interpolation and Adaptive Networks , 1988 .
[35] J. L. Durant,et al. Reoptimization of MDL Keys for Use in Drug Discovery. , 2003 .
[36] D. Kell,et al. Distributed under Creative Commons Cc-by 4.0 the Apparent Permeabilities of Caco-2 Cells to Marketed Drugs: Magnitude, and Independence from Both Biophysical Properties and Endogenite Similarities , 2022 .
[37] T. Ishikawa,et al. Pharmacogenomics of Human Drug Transporters: Clinical Impacts , 2013 .
[38] A. Tropsha,et al. Human Intestinal Transporter Database: QSAR Modeling and Virtual Profiling of Drug Uptake, Efflux and Interactions , 2013, Pharmaceutical Research.
[39] G. V. Paolini,et al. Quantifying the chemical beauty of drugs. , 2012, Nature chemistry.
[40] D. Kell,et al. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? , 2008, Nature Reviews Drug Discovery.
[41] P. Sneath,et al. Numerical Taxonomy , 1962, Nature.
[42] G. Maggiora,et al. Molecular similarity in medicinal chemistry. , 2014, Journal of medicinal chemistry.
[43] Weifan Zheng,et al. Novel Approach to Structure-Based Pharmacophore Search Using Computational Geometry and Shape Matching Techniques , 2008, J. Chem. Inf. Model..
[44] Uko Maran,et al. QSAR DataBank - an approach for the digital organization and archiving of QSAR model information , 2014, Journal of Cheminformatics.
[45] Thorsten Meinl,et al. KNIME-CDK: Workflow-driven cheminformatics , 2013, BMC Bioinformatics.
[46] Christoph Steinbeck,et al. Natural product-likeness score revisited: an open-source, open-data implementation , 2012, BMC Bioinformatics.
[47] S. Golz,et al. Discovery of the ergothioneine transporter. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[48] C. Peota. Novel approach. , 2011, Minnesota medicine.
[49] José L. Medina-Franco,et al. MOLECULAR SIMILARITY ANALYSIS , 2013 .
[50] Sereina Riniker,et al. Heterogeneous Classifier Fusion for Ligand-Based Virtual Screening: Or, How Decision Making by Committee Can Be a Good Thing , 2013, J. Chem. Inf. Model..
[51] Pierre Baldi,et al. Large scale study of multiple-molecule queries , 2009, J. Cheminformatics.
[52] Pierre Baldi,et al. When is Chemical Similarity Significant? The Statistical Distribution of Chemical Similarity Scores and Its Extreme Values , 2010, J. Chem. Inf. Model..
[53] Neil Swainston,et al. An analysis of a ‘community-driven’ reconstruction of the human metabolic network , 2013, Metabolomics.
[54] David S. Broomhead,et al. Multivariable Functional Interpolation and Adaptive Networks , 1988, Complex Syst..
[55] Nina Jeliazkova,et al. Toxmatch--a chemical classification and activity prediction tool based on similarity measures. , 2008, Regulatory toxicology and pharmacology : RTP.
[56] Geoffrey E. Hinton. Learning multiple layers of representation , 2007, Trends in Cognitive Sciences.
[57] Valerie J. Gillet,et al. Investigation of the Use of Spectral Clustering for the Analysis of Molecular Data , 2014, J. Chem. Inf. Model..
[58] Naomie Salim,et al. Combination of Fingerprint-Based Similarity Coefficients Using Data Fusion , 2003, J. Chem. Inf. Comput. Sci..
[59] Peter Ertl,et al. Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries , 2008, J. Chem. Inf. Model..
[60] A. Tversky. Features of Similarity , 1977 .
[61] Douglas B. Kell,et al. Statistical strategies for avoiding false discoveries in metabolomics and related experiments , 2007, Metabolomics.
[62] Yee Whye Teh,et al. A Fast Learning Algorithm for Deep Belief Nets , 2006, Neural Computation.
[63] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[64] Dennis H. Rouvray,et al. Definition and role of similarity concepts in the chemical and physical sciences , 1992, J. Chem. Inf. Comput. Sci..
[65] Sunil Gupta,et al. Comparing the chemical spaces of metabolites and available chemicals: models of metabolite-likeness , 2007, Molecular Diversity.
[66] Douglas B. Kell,et al. Computational cluster validation in post-genomic data analysis , 2005, Bioinform..
[67] Yiqun Cao,et al. ChemMine tools: an online service for analyzing and clustering small molecules , 2011, Nucleic Acids Res..
[68] Douglas B. Kell,et al. Implications of endogenous roles of transporters for drug discovery: hitchhiking and metabolite-likeness , 2016, Nature Reviews Drug Discovery.
[69] Thorsten Meinl,et al. KNIME: The Konstanz Information Miner , 2007, GfKl.
[70] Kam Y. J. Zhang,et al. A rotation-translation invariant molecular descriptor of partial charges and its use in ligand-based virtual screening , 2014, Journal of Cheminformatics.
[71] Ray M. Marín,et al. Graph Theoretical Similarity Approach to Compare Molecular Electrostatic Potentials. , 2008 .
[72] Artem Cherkasov,et al. Comparative QSAR- and Fragments Distribution Analysis of Drugs, Druglikes, Metabolic Substances, and Antimicrobial Compounds , 2006, J. Chem. Inf. Model..
[73] Darren R. Flower,et al. On the Properties of Bit String-Based Measures of Chemical Similarity , 1998, J. Chem. Inf. Comput. Sci..
[74] Douglas B Kell,et al. What would be the observable consequences if phospholipid bilayer diffusion of drugs into cells is negligible? , 2015, Trends in pharmacological sciences.
[75] Guofeng You,et al. Drug transporters : molecular characterization and role in drug disposition , 2014 .
[76] D. Gründemann. The ergothioneine transporter controls and indicates ergothioneine activity--a review. , 2012, Preventive medicine.
[77] Neil Swainston,et al. A ‘rule of 0.5’ for the metabolite-likeness of approved pharmaceutical drugs , 2014, Metabolomics.
[78] Anna Vulpetti,et al. Making sure there's a "give" associated with the "take": producing and using open-source software in big pharma , 2011, J. Cheminformatics.
[79] Douglas B Kell,et al. Implications of the dominant role of transporters in drug uptake by cells. , 2009, Current topics in medicinal chemistry.
[80] Ines Thiele,et al. Membrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease , 2014, Front. Physiol..
[81] B. Palsson. Systems Biology: Constraint-based Reconstruction and Analysis , 2015 .
[82] Xiaojin Zhu,et al. Introduction to Semi-Supervised Learning , 2009, Synthesis Lectures on Artificial Intelligence and Machine Learning.
[83] Douglas B. Kell,et al. Software review: the KNIME workflow environment and its applications in genetic programming and machine learning , 2015, Genetic Programming and Evolvable Machines.
[84] Ronan M. T. Fleming,et al. A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.
[85] Gisbert Schneider,et al. Distance phenomena in high-dimensional chemical descriptor spaces: consequences for similarity-based approaches , 2009 .
[86] T. Fukushima,et al. Inhibition of D-amino acid oxidase activity by antipsychotic drugs evaluated by a fluorometric assay using D-kynurenine as substrate. , 2011, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[87] R. Rivlin,et al. Accelerated development of riboflavin deficiency by treatment with chlorpromazine. , 1983, Biochemical pharmacology.
[88] M. Hediger,et al. The ABCs of membrane transporters in health and disease (SLC series): Introduction , 2013, Molecular aspects of medicine.
[89] D. Kell,et al. The cellular uptake of pharmaceutical drugs is mainly carrier-mediated and is thus an issue not so much of biophysics but of systems biology , 2009 .
[90] D. Kell,et al. Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it , 2013, The FEBS journal.
[91] J. Dearden,et al. QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.
[92] Peter Willett,et al. The Calculation of Molecular Structural Similarity: Principles and Practice , 2014, Molecular informatics.
[93] P Willett,et al. Grouping of coefficients for the calculation of inter-molecular similarity and dissimilarity using 2D fragment bit-strings. , 2002, Combinatorial chemistry & high throughput screening.
[94] Sereina Riniker,et al. Open-source platform to benchmark fingerprints for ligand-based virtual screening , 2013, Journal of Cheminformatics.
[95] Marvin Johnson,et al. Concepts and applications of molecular similarity , 1990 .
[96] L. Pollegioni,et al. Effect of ligand binding on human D‐amino acid oxidase: Implications for the development of new drugs for schizophrenia treatment , 2010, Protein science : a publication of the Protein Society.
[97] Jürgen Bajorath,et al. Balancing the Influence of Molecular Complexity on Fingerprint Similarity Searching. , 2008 .
[98] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[99] D. Kell,et al. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries. , 2009, Drug discovery today.
[100] S. Wold,et al. PLS-regression: a basic tool of chemometrics , 2001 .
[101] Joshua D. Knowles,et al. Semi-supervised feature selection via multiobjective optimization , 2006, The 2006 IEEE International Joint Conference on Neural Network Proceedings.
[102] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[103] James G. Nourse,et al. Reoptimization of MDL Keys for Use in Drug Discovery , 2002, J. Chem. Inf. Comput. Sci..
[104] Guigang Zhang,et al. Deep Learning , 2016, Int. J. Semantic Comput..
[105] Douglas B Kell,et al. Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast , 2011, BMC Biology.
[106] Max Welling,et al. Semi-supervised Learning with Deep Generative Models , 2014, NIPS.
[107] Yuan Wang,et al. Using Information from Historical High-Throughput Screens to Predict Active Compounds , 2014, J. Chem. Inf. Model..
[108] Douglas B Kell,et al. Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. , 2011, Drug discovery today.
[109] Lemont B. Kier,et al. Molecular Similarity Based on Novel Atom-Type Electrotopological State Indices , 1995, J. Chem. Inf. Comput. Sci..
[110] Yoshua. Bengio,et al. Learning Deep Architectures for AI , 2007, Found. Trends Mach. Learn..
[111] Ayhan Demiriz,et al. Semi-Supervised Clustering Using Genetic Algorithms , 1999 .
[112] B. Heraud,et al. The Analysis of the Community , 1970 .
[113] Peter S. Kutchukian,et al. Rethinking molecular similarity: comparing compounds on the basis of biological activity. , 2012, ACS chemical biology.
[114] Andreas Bender,et al. Understanding and Classifying Metabolite Space and Metabolite-Likeness , 2011, PloS one.
[115] Drug Transporters , 2012 .
[116] Artem Cherkasov,et al. Can 'Bacterial-Metabolite-Likeness' Model Improve Odds of 'in Silico' Antibiotic Discovery? , 2006, J. Chem. Inf. Model..
[117] S-M Huang,et al. Transporters in Drug Development and Clinical Pharmacology , 2013, Clinical pharmacology and therapeutics.
[118] Ryan G. Coleman,et al. ZINC: A Free Tool to Discover Chemistry for Biology , 2012, J. Chem. Inf. Model..
[119] Robert C. Glen,et al. Chapter 9 Molecular Similarity: Advances in Methods, Applications and Validations in Virtual Screening and QSAR , 2006, Annual Reports in Computational Chemistry.
[120] Ashutosh Kumar Singh,et al. The Elements of Statistical Learning: Data Mining, Inference, and Prediction , 2010 .
[121] Gregory A Landrum,et al. Is that a scientific publication or an advertisement? Reproducibility, source code and data in the computational chemistry literature. , 2012, Future medicinal chemistry.
[122] M. Niemi,et al. Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.
[123] D. Kell,et al. The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. , 2013, Drug discovery today.
[124] Ajay N. Jain,et al. Molecular Shape and Medicinal Chemistry: A Perspective , 2010, Journal of medicinal chemistry.
[125] Geoffrey E. Hinton,et al. Reducing the Dimensionality of Data with Neural Networks , 2006, Science.
[126] Jürgen Bajorath,et al. Balancing the Influence of Molecular Complexity on Fingerprint Similarity Searching , 2008, J. Chem. Inf. Model..
[127] D. Kell,et al. Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery☆ , 2014, Drug discovery today.
[128] David S. Wishart,et al. DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..
[129] Douglas B. Kell,et al. Fitting Transporter Activities to Cellular Drug Concentrations and Fluxes: Why the Bumblebee Can Fly , 2015, Trends in pharmacological sciences.
[130] Peter Brandt,et al. Identification of a novel scaffold for allosteric inhibition of wild type and drug resistant HIV-1 reverse transcriptase by fragment library screening. , 2011, Journal of medicinal chemistry.
[131] Pierre Baldi,et al. ChemDB: a public database of small molecules and related chemoinformatics resources , 2005, Bioinform..
[132] S. L. Dixon,et al. The hidden component of size in two-dimensional fragment descriptors: side effects on sampling in bioactive libraries. , 1999, Journal of medicinal chemistry.
[133] Katsuhisa Inoue,et al. Transport Functions of Riboflavin Carriers in the Rat Small Intestine and Colon: Site Difference and Effects of Tricyclic-Type Drugs , 2001, Drug delivery.
[134] Douglas B. Kell,et al. How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion , 2014, Front. Pharmacol..
[135] Douglas B. Kell,et al. The transporter-mediated cellular uptake of pharmaceutical drugs is based on their metabolite-likeness and not on their bulk biophysical properties: Towards a systems pharmacology ☆ , 2015 .
[136] John J Irwin,et al. Using ZINC to Acquire a Virtual Screening Library , 2008, Current protocols in bioinformatics.
[137] Maria-Florina Balcan,et al. A discriminative model for semi-supervised learning , 2010, J. ACM.